Entry Detail



General Information

Database ID:exR0012390
RNA Name:RPS14
RNA Type:mRNA
Chromosome:chr5
Starnd:-
Coordinate:
Start Site(bp):150442635End Site(bp):150449739
External Links:ENSG00000164587



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC068580.4
chr11
1734821
1763954
-
ALDOA
chr16
30064164
30070457
+
ACTG1
chr17
81509971
81523847
-
ACTB
chr7
5527148
5563784
-
ADSL
chr22
40346500
40390463
+
AL136295.1
chr14
24189157
24213473
-
ABLIM1
chr10
114431113
114768061
-
AHCYL1
chr1
109984765
110023742
+
ALDH2
chr12
111766887
111817532
+
ADARB1
chr21
45073853
45226560
+
AC004922.1
chr7
99325879
99394653
+
AC009133.6
chr16
29812261
29820092
+
AASS
chr7
122073549
122144255
-
ACSL4
chrX
109624244
109733403
-
AFAP1
chr4
7758714
7939926
-
AL136295.4
chr14
24180395
24190416
-
AHCYL2
chr7
129225023
129430211
+
AL160269.1
chr9
96235331
96352058
-
ADI1
chr2
3497366
3519531
-
ACTR3
chr2
113890063
113962596
+
ADGRE5
chr19
14380501
14408725
+
AL513165.2
chr9
37512547
37592469
-
AKAP1
chr17
57085092
57121346
+
AC026954.2
chr17
7312661
7319174
-
AL162417.1
chr9
133098121
133163914
-
AKAP17A
chrX
1591604
1602520
+
AL133352.1
chr10
100505628
100529881
-
ADPGK
chr15
72751369
72785846
-
AC027796.3
chr17
3585149
3636249
-
AC004832.3
chr22
30409255
30428990
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-6891-3p
chr6
31355228
31355248
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC010642.2
chr19
58309727
58327248
-
AC013268.5
chr2
109937438
109985124
+
AC018521.5
chr17
47891229
47895812
-
AC024940.6
chr12
31280422
31280895
-
AC040162.3
chr16
67882461
67886367
+
AC063949.2
chr12
92421531
92483680
+
AC104109.4
chr5
134205614
134371044
-
AC125257.1
chr17
41848518
41851447
-
AC132217.1
chr11
2129121
2129964
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.